CStone Pharmaceuticals — Board/Management Information 2020

Nov 30, 2020

==> picture [116 x 37] intentionally omitted <==

CStone Pharmaceuticals 基石藥業

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2616)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the “ Board ”) of CStone Pharmaceuticals (the “ Company ”) are set out below.

Executive director

Dr. Frank Ningjun Jiang (Chairman and Chief Executive Officer)

Non-executive directors

• Dr. Wei Li

• Mr. Qun Zhao

• Mr. Yanling Cao

• Mr. Xianghong Lin

• Dr. Lian Yong Chen

Independent non-executive directors

Dr. Paul Herbert Chew

• Mr. Ting Yuk Anthony Wu

• Mr. Hongbin Sun

The Board has four Board committees. The table below provides the membership information of these committees on which each director of the Company serves.

	Audit Committee	Compensation Committee	Nomination Committee	Strategy Committee
Dr. Frank Ningjun Jiang			C	C
Dr. Wei Li		M
Mr. Qun Zhao
Mr. Yanling Cao			M
Mr. Xianghong Lin
Dr. Lian Yong Chen				M
Dr. Paul Herbert Chew	M	M	M	M
Mr. Ting Yuk Anthony Wu	M	C	M
Mr. Hongbin Sun	C		M

Notes:

C Chairman of the relevant Board committee M Member of the relevant Board committee

November 30, 2020